Delbanco T L, Meyers K C, Segal E A
N Engl J Med. 1979 Dec 13;301(24):1314-20. doi: 10.1056/NEJM197912133012404.
At a time of debate over physicians' fees and income, we describe the evolution of Blue Shield plans and programs to pay physicians' fees. We review how Medicare's "reasonable-charge" formulas fostered Blue Shield "usual, customary, and reasonable" (UCR) contracts. In a three-year period in the Washington, DC, area, Blue Shield UCR protocols permitted "customary" allowances for selected surgical procedures to rise 29 to 75 per cent; charges by two physicians increased allowances for coronary-artery bypass from $2000 to $3500. We find little justification for secrecy in fee-payment protocols. Physicians dominate the District of Columbia Blue Shield Board and its committees, and they control fee-payment formulas. Nationally, 61 per cent of Blue Shield boards have majorities of health-care providers; approximately two thirds of fee-related committees have physician majorities. We urge increased public debate, public representation, and accountability in monitoring and reforming the programs that we describe.
在关于医生费用和收入的争论时期,我们描述了蓝盾计划以及支付医生费用的方案的演变。我们回顾了医疗保险的“合理收费”公式如何促成了蓝盾的“惯常、习俗和合理”(UCR)合同。在华盛顿特区地区的三年时间里,蓝盾UCR协议允许某些外科手术的“习俗性”补贴提高29%至75%;两位医生的收费将冠状动脉搭桥手术的补贴从2000美元提高到了3500美元。我们发现,在费用支付协议中几乎没有保密的正当理由。医生在哥伦比亚特区蓝盾委员会及其委员会中占主导地位,他们控制着费用支付公式。在全国范围内,61%的蓝盾委员会中医疗保健提供者占多数;约三分之二与费用相关的委员会中医生占多数。我们敦促在监测和改革我们所描述的这些方案时,增加公众辩论、公众代表参与度以及问责制。